Corrado E, Bacarella D, Coppola G, Rizzo M, Muratori I, Dell'oglio S, Nugara C, Ferrara F, Novo S
Division of Cardiology, Paolo Giaccone University Hospital, University of Palermo, via del Vespro 127, Palermo, Italy.
Int Angiol. 2012 Feb;31(1):1-9.
The management of carotid artery disease includes both modifications in life style as well treatment of vascular risk factors. However, strict risk factor modification, including improved antihypertensive therapy, lipid management, smoking cessation, and antiplatelet therapy, promise for reducing the vascular event rate in patients with carotid atherosclerosis. The best medical management for stroke prevention was highlighted in clinical practice guidelines issued jointly in 2006 by the American Heart Association and the American Stroke Association, and co-sponsored by the Council on Cardiovascular Radiology and Intervention and the American Academy of Neurology. Lowering blood pressure to a target below 120/80 mm Hg by life style interventions and antihypertensive treatment. Glucose control to near-normoglycemic levels (target hemoglobin A1C ≤7%) is recommended among diabetics to reduce micro-vascular complications and, with lesser certainty, macrovascular complications. The primary objective of this review is to summarize the current evidence and standards for the advanced diagnostic and management strategies used in asymptomatic and symptomatic patients with carotid atherosclerosis.
颈动脉疾病的管理包括生活方式的改变以及血管危险因素的治疗。然而,严格的危险因素控制,包括改善抗高血压治疗、血脂管理、戒烟和抗血小板治疗,有望降低颈动脉粥样硬化患者的血管事件发生率。美国心脏协会和美国中风协会于2006年联合发布,并由心血管放射学与介入理事会和美国神经病学学会共同赞助的临床实践指南中强调了预防中风的最佳药物治疗方法。通过生活方式干预和抗高血压治疗将血压降至120/80 mmHg以下的目标值。建议糖尿病患者将血糖控制在接近正常血糖水平(目标糖化血红蛋白A1C≤7%),以减少微血管并发症,并在一定程度上减少大血管并发症。本综述的主要目的是总结目前用于无症状和有症状颈动脉粥样硬化患者的先进诊断和管理策略的证据和标准。